CAD 6.11
(-4.83%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 186.37 Million CAD | 44.68% |
2022 | 128.82 Million CAD | -7.93% |
2021 | 139.92 Million CAD | 1.6% |
2020 | 137.72 Million CAD | -12.43% |
2019 | 157.26 Million CAD | -4.96% |
2018 | 165.47 Million CAD | 282.92% |
2017 | 43.21 Million CAD | 266.51% |
2016 | 11.79 Million CAD | 183.28% |
2015 | 4.16 Million CAD | 16281.3% |
2014 | 25.4 Thousand CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
2007 | - CAD | 0.0% |
2006 | - CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 Q1 | 139.22 Million CAD | 11.51% |
2023 Q2 | 143.95 Million CAD | 3.4% |
2023 Q3 | 186.37 Million CAD | 29.47% |
2023 FY | 186.37 Million CAD | 44.68% |
2022 Q4 | 124.85 Million CAD | -3.08% |
2022 Q2 | 122.59 Million CAD | -16.17% |
2022 FY | 128.82 Million CAD | -7.93% |
2022 Q3 | 128.82 Million CAD | 5.08% |
2022 Q1 | 146.24 Million CAD | 4.51% |
2021 Q2 | 149.53 Million CAD | -4.04% |
2021 Q1 | 155.81 Million CAD | 13.14% |
2021 FY | 139.92 Million CAD | 1.6% |
2021 Q4 | 139.92 Million CAD | 7.72% |
2021 Q3 | 129.9 Million CAD | -13.13% |
2020 Q2 | 200.81 Million CAD | 8.71% |
2020 FY | 137.72 Million CAD | -12.43% |
2020 Q4 | 137.72 Million CAD | 12.05% |
2020 Q3 | 122.91 Million CAD | -38.79% |
2020 Q1 | 184.73 Million CAD | 17.47% |
2019 FY | 157.26 Million CAD | -4.96% |
2019 Q2 | 251.16 Million CAD | 24.03% |
2019 Q1 | 202.49 Million CAD | 22.37% |
2019 Q3 | 281.76 Million CAD | 12.18% |
2019 Q4 | 157.26 Million CAD | -44.19% |
2018 Q3 | 134.9 Million CAD | 40.73% |
2018 Q1 | 85.35 Million CAD | 97.51% |
2018 FY | 165.47 Million CAD | 282.92% |
2018 Q2 | 95.86 Million CAD | 12.31% |
2018 Q4 | 165.47 Million CAD | 22.66% |
2017 Q4 | 43.21 Million CAD | 33.54% |
2017 FY | 43.21 Million CAD | 266.51% |
2017 Q3 | 32.36 Million CAD | 52.79% |
2017 Q2 | 21.18 Million CAD | 19.42% |
2017 Q1 | 17.73 Million CAD | 50.42% |
2016 Q4 | 11.79 Million CAD | 35.63% |
2016 Q1 | 3.1 Million CAD | -25.45% |
2016 Q2 | 5.71 Million CAD | 84.28% |
2016 Q3 | 8.69 Million CAD | 52.03% |
2016 FY | 11.79 Million CAD | 183.28% |
2015 Q2 | 3.21 Million CAD | 923.82% |
2015 Q1 | 314.35 Thousand CAD | 1137.19% |
2015 FY | 4.16 Million CAD | 16281.3% |
2015 Q4 | 4.16 Million CAD | -49.06% |
2015 Q3 | 8.17 Million CAD | 153.87% |
2014 Q2 | - CAD | 0.0% |
2014 FY | 25.4 Thousand CAD | 0.0% |
2014 Q4 | 25.4 Thousand CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q3 | - CAD | -100.0% |
2009 Q1 | - CAD | 0.0% |
2009 Q2 | 1500.00 CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
2007 Q2 | - CAD | 0.0% |
2007 Q1 | - CAD | 0.0% |
2007 FY | - CAD | 0.0% |
2007 Q4 | - CAD | 0.0% |
2007 Q3 | - CAD | 0.0% |
2006 FY | - CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Avicanna Inc. | 4.54 Million CAD | -4001.37% |
Avant Brands Inc. | 28.93 Million CAD | -544.075% |
Cardiol Therapeutics Inc. | -279.87 Thousand CAD | 66693.3% |
Crescita Therapeutics Inc. | 6.12 Million CAD | -2942.873% |
Knight Therapeutics Inc. | 91.83 Million CAD | -102.949% |
MediPharm Labs Corp. | 9.89 Million CAD | -1782.776% |
OrganiGram Holdings Inc. | 80.95 Million CAD | -130.227% |
Canopy Growth Corporation | 77.29 Million CAD | -141.132% |
Willow Biosciences Inc. | 221 Thousand CAD | -84233.032% |
Auxly Cannabis Group Inc. | 31.42 Million CAD | -493.006% |